Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
366 Leser
Artikel bewerten:
(1)

PPJ Healthcare Enterprises, Inc. Announces that its CEO Prevails in Court

TAMPA, FL / ACCESSWIRE / May 13, 2021 / PPJ Enterprise (OTC PINK:PPJE) ("the Company"), a leader in Healthcare Reimbursement Cycle Expert for Complex Medical/Surgical Services and proprietary Automated Healthcare Practice Management /billing Software, online Health Information Digital Systems, and Medical Practice Information Management is pleased to announce that its CEO Ms. Basu prevails "Court in Los Angeles accepted the case against Narinder S. Grewal, MD of Valencia, California and his lawyer Jerome Arnaiz and its former trial counsel Michael J. Hemming. The case is set for trial in September of 2022.

Both the lawyers tried to demurrer (dismiss) the complaint on various grounds. The judge ruled he will not entertain any demurrers" "Anyone may have questions regarding the disclosure made for this lawsuit, please review the Company's 'OTC DISCLOSURE STATEMENTS of Annual Report and subsequent Disclosure Statements filed on the OTCMARKETS.com"

PPJE, under Ms. Basu's management, retains some of the highest ratings in the healthcare industry and remain at the cutting edge of healthcare reimbursement management, especially for interventional pain management, anesthesia, surgery centers, LDL Apheresis, EMS fire and Emergency ambulance service, and other complex specialties of medicine for the past 31 years.

For information, please contact:
Shareholders' Services
Email: info@ppjenterprise.com
Website: https://www.ppjenterprise.com
Twitter: @PPJEnterprise

Forward-Looking Statements

Information in this release may contain statements about future expectations, plans, prospects, or performance of PPJ Enterprise that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. PPJ Healthcare Enterprises, Inc. cautions you that any forward-looking information provided by or on behalf of PPJ Healthcare Enterprises, Inc. is not a guarantee of future performance. None of the information in this press release constituted or is intended as an offer to sell securities or investment advice of any kind. PPJ Healthcare Enterprises, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements due to various important factors, some of which are beyond PPJ Healthcare Enterprises, Inc.'s control. In addition to those discussed in PPJ Healthcare Enterprises, Inc.'s press releases, public filings, and statements by PPJ Healthcare Enterprises, Inc.'s management, including, but not limited to, PPJ Healthcare Enterprises, Inc.'s estimate of the sufficiency of its existing capital resources, PPJ Healthcare Enterprises, Inc.'s ability to raise additional capital to fund future operations, PPJ Healthcare Enterprises, Inc.'s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities, and in identifying contracts that match PPJ Healthcare Enterprises, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on when the Company made the statements PPJ Healthcare Enterprises, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made to reflect the occurrence of unanticipated events.

SOURCE: PPJ Healthcare Enterprises, Inc.



View source version on accesswire.com:
https://www.accesswire.com/647198/PPJ-Healthcare-Enterprises-Inc-Announces-that-its-CEO-Prevails-in-Court

© 2021 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.